3Indexed trials
drug · Product Intelligence
Droxidopa
Pipeline Intelligence
Droxidopa: 3 indexed trials, 2 sponsors; 0 linked Orange Book patents and 7 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
7FDA-linked events
Development evidence
NCT00633880Chelsea Therapeutics · movement_disordersPHASE3
NCT01176240Chelsea Therapeutics · parkinsonsPHASE3
NCT02897063Vanderbilt University Medical Center · parkinsonsPHASE1
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALDROXIDOPA · 2021-11-01
FDA_APPROVALDROXIDOPA · 2021-05-05
FDA_APPROVALDROXIDOPA · 2021-04-28
FDA_APPROVALDROXIDOPA · 2021-02-18
FDA_APPROVALDROXIDOPA · 2021-02-18
FDA_APPROVALDROXIDOPA · 2021-02-18
FDA_APPROVALDROXIDOPA · 2021-02-18
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.